UCSF Researchers Identify FTL1 Protein as Primary Driver of Brain Aging and Memory Decline

UCSF scientists find that reducing the FTL1 protein can reverse memory decline and rebuild neural connections. A new hope for age-related cognitive therapy.

By: AXL Media

Published: Apr 6, 2026, 9:05 AM EDT

Source: Information for this report was sourced from ScienceDaily

The Discovery of a Molecular Sentinel in the Hippocampus

Aging exerts a profound impact on the hippocampus, the critical brain region responsible for learning and memory formation. Researchers at the University of California, San Francisco (UCSF) have now identified a single protein, FTL1, which appears to be a central catalyst for this biological degradation. By tracking shifts in genes and proteins within the hippocampi of mice over time, the team found that FTL1 was the only factor that remained consistently and significantly different between young and old subjects. This suggests that the accumulation of this specific protein serves as a biological marker for the aging brain.

Structural Decay Triggered by Protein Accumulation

The study revealed a direct correlation between FTL1 levels and the physical integrity of the brain’s neural networks. In older mice, high concentrations of FTL1 were accompanied by a noticeable decrease in the connections between neurons. To test this relationship, researchers artificially boosted FTL1 levels in young mice, observing that their brains quickly began to mirror the simplified structures and diminished cognitive function of much older animals. Specifically, nerve cells with excessive FTL1 stopped forming complex, branching networks, instead developing stunted, single extensions that hampered communication across the brain.

Reversing Cognitive Impairment Through Protein Reduction

The most significant breakthrough occurred when the research team moved beyond observation to active intervention. By reducing FTL1 levels in older mice, they achieved what senior author Saul Villeda, PhD, described as a genuine reversal of impairments rather than a mere delay of symptoms. Following the reduction of the protein, the aged mice began to rebuild lost neural connections and demonstrated marked improvements in standardized memory tests. This finding challenges the long-held assumption that age-related cognitive decline is an irreversible one-way process.